---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-23-000033"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2023-11-09T23:59:59+00:00"
generated_at: "2026-06-08T07:22:53.658179+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# GoodRx Q3 revenue $180M; adjusted revenue $190M, net loss $38.5M

## Summary
- Revenue of $180.0M, reduced by $10M client contract termination; adjusted revenue $190.0M.
- Net loss $38.5M (21.4% margin); adjusted net income $25.5M (13.4% margin).
- Adjusted EBITDA $53.5M (28.1% margin); operating cash flow $60.3M.
- Over 550K prescribers via Provider Mode; >7M consumers of prescription offerings.

## SEC filing metadata
- accession: 0001809519-23-000033
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2023-11-09T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/0001809519-23-000033-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/gdrx-20231109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-23-000033
- JSON: https://secwatch.observer/filing/0001809519-23-000033.json
- Plain text: https://secwatch.observer/filing/0001809519-23-000033.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. reported financial results for three and nine months ended September 30, 2023.
  - Period: three and nine months ended September 30, 2023
  - Result: reported results
  source text: On November 9, 2023, GoodRx Holdings, Inc. (the “Company”) announced the Company’s financial results for the three and nine months ended September 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951923000033/0001809519-23-000033-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.